Longcor Jarrod 4
4 · Cellectar Biosciences, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Longcor Jarrod
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2025-02-14+500,000→ 500,000 totalExercise: $0.29Exp: 2035-02-14→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026.